23andMe filed for Chapter 11 bankruptcy protection earlier this year. The company’s shares currently trade on the OTC Pink Market, with InvestingPro analysis showing the stock has experienced high ...

Office of the Utah Attorney General and the Utah Department of Commerce's Division of Consumer Protection are issuing a ...

Following the sale of the direct-to-consumer genetic testing company 23andMe, the Utah Attorney General’s Office is issuing a ...

This transaction, part of 23andMe’s Chapter 11 bankruptcy proceedings, is subject to U.S. Bankruptcy Court approval, with a hearing scheduled for June 17, 2025.

The computer systems of 23andMe have been struggling to cope with the sheer volume of customers racing to delete their data, after the DNA-testing company announced that it was filing for ...

Your DNA results are in — and they're 100% the property of a pharmaceutical manufacturer. It was announced today that 23andMe, the consumer-genomics company that sold take-home DNA kits, will be ...

23andMe filed for Chapter 11 bankruptcy protection on Sunday. Anne Wojcicki, who co-founded the company nearly two decades ago and has served as its CEO, stepped down effectively immediately.

What’s Happening With the 23andMe Data Sale 23andMe is a company that sells genetic testing kits. People send in a saliva sample and receive information about their ancestry and health. 23andMe ...

Genetic testing company 23andMe has filed for bankruptcy, prompting concerns over data privacy. Source: Getty / Justin Sullivan In 2008, genetic DNA testing was all the rage.

Many 23andMe customers signed up to the genetic testing service in hopes of learning fun or interesting information about their past. But consumer advocates are now urging those users to request ...

Regeneron acquires 23andMe for $256M following bankruptcy auction Regeneron will take over key assets including 23andMe’s Personal Genome Service, Biobank, Total Health, and research operations, ...

All of 23andme's existing data protection provisions were to be maintained, and the genetic analysis business for private individuals was to be continued. 23andme was to remain a subsidiary.